I have to admit, coming up with the 9th edition of DNA Genotek's "Top 10 list" was much more difficult than I imagined it would be. There are so many great things that happened in the past year - in our company, with our customers, and in the fields of genetics, microbiome and infectious disease - but I think I've narrowed it down to those that are most significant. The list is by no means comprehensive, but these are the 10 things I'll remember most from 2017.Read More
DNA Genotek's Sample Collection Blog
At the 2013 American Society for Human Genetics (ASHG) conference in Boston last month, we launched the first version of DNA Genotek’s Activity Calendar for science fanatics. We wanted to provide ASHG attendees who visited our booth a way to celebrate scientific achievement in a fun way. The end result is a glossy, full color, 13-month desk calendar that features a variety of puzzles, challenges and games. Each month includes an online challenge which must be completed to be entered into a draw for a 32GB Apple iPad Mini (Wi-Fi version).
Mike Tayeb is the manager of technical support at DNA Genotek.
Dr. Hugh Rienhoff is well known as a technology visionary, entrepreneur, and venture investor in life sciences. In addition to his current role as CEO of FerroKin BioSciences, and his appointment as a Visiting Scientist at the Children’s Hospital Oakland Research Institute, he has also founded the nonprofit organization MyDaughtersDNA.org, a community focused on aiding those with diagnostically challenging genetic conditions. It was not simply that he was a trained clinical geneticist and had the background and resources to spur this effort. The motivation was simple: Dr. Rienhoff ‘s daughter was born with an unknown genetic disorder. She exhibited a puzzling array of symptoms including small muscles -- no one is sure what might lie in her future because no one is sure what is wrong with her.
DNA from Oragene/saliva samples continues to gain acceptance as a suitable sample input for next generation sequencing technologies (NGS) from targeted to exome to whole genome sequencing. The latest development in this body of evidence is the recent announcement by Complete Genomics that they will now accept DNA from Oragene/saliva samples for whole genome sequencing.